Literature DB >> 23088420

Prevalence, molecular characteristics and risk factors for cryptosporidiosis among Iranian immunocompromised patients.

Morteza Izadi1, Nematollah Jonaidi-Jafari, Amin Saburi, Hossein Eyni, Mohammad-Reza Rezaiemanesh, Reza Ranjbar.   

Abstract

Cryptosporidium spp. is a major cause of diarrhea in developing countries, mainly affecting people with compromised immune systems in general and HIV-infected individuals with low CD4 + T-cell counts in particular. This infection is self-limiting in healthy persons; however, it can be severe, progressive and persistent in those who are immunocompromised. There are few published studies concerning cryptosporidiosis and Cryptosporidium genotypes in Iranian immunocompromised patients and none of them describe risk factors. This study was undertaken to identify prevalence, genotypes and risk factors for cryptosporidiosis in immunocompromised patients. Three fecal samples were obtained at two day intervals from each of the 183 patients and processed with modified Ziehl-Neelsen staining methods and 18S rRNA gene amplification and sequencing. The overall infection prevalence was 6%. Cryptosporidium parvum was identified in isolates from five HIV-infected patients, one patient who had undergone bone marrow transplantation and one with chronic lymphocytic leukemia. Cryptosporidium hominis was identified in isolates from two HIV-infected patients and two patients with acute lymphocytic leukemia. According to univariate analysis, the statistically significant factors were diarrhea (OR = 21.7, CI = 2.83-78.4, P= 0.003), CD4 + lymphocytes less than 100 cells/mm(3) (OR = 41.3, CI = 13.45-114.8, P < 0.0001), other microbial infections (OR = 7.1321.7, CI = 1.97-25.73, P = 0.006), weight loss (OR = 73.78, CI = 15.5-350, P < 0.0001), abdominal pain (OR = 10.29, CI = 2.81-37.74.4, P= 0.001), dehydration (OR = 72.1, CI = 17.6-341.5, P < 0.0001), vomiting (OR = 4.87, CI = 1.4-16.9, P= 0.015), nausea (OR = 9.4, CI = 2.38-37.2, P < 0.001), highly active antiretroviral therapy (OR = 0.089, CI = 0.01-0.8, P= 0.015) and diarrhea in household members (OR = 7.37, CI = 2.04-26.66, P= 0.001). After multivariate analysis and a backward deletion process, only < 100 CD4 + T-lymphocytes/mm(3) maintained a significant association with infection. The authors recommend that this infection should be suspected in patients with diarrhea, weight loss and dehydration in general and in diarrheal individuals with < 100 CD4 + T-lymphocytes/mm(3).
© 2012 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23088420     DOI: 10.1111/j.1348-0421.2012.00513.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  15 in total

1.  Cryptosporidium infection in children with cancer undergoing chemotherapy: how important is the prevention of opportunistic parasitic infections in patients with malignancies?

Authors:  Reza Berahmat; Mahmoud Mahami-Oskouei; Azim Rezamand; Adel Spotin; Nayyereh Aminisani; Roghayeh Ghoyounchi; Solmaz Madadi
Journal:  Parasitol Res       Date:  2017-07-20       Impact factor: 2.289

2.  Genetic characterization of Cryptosporidium spp. among patients with gastrointestinal complaints.

Authors:  Reza Ranjbar; Kaveh Baghaei; Ehsan Nazemalhosseini Mojarad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016

3.  Prevalence and Genetic Characterization of Cryptosporidium and Microsporidia Infecting Hematological Malignancy Patients.

Authors:  Ujjala Ghoshal; Sonali K Kalra; Nidhi Tejan; Prabhat Ranjan; Asmita Dey; Soniya Nityanand
Journal:  Acta Parasitol       Date:  2020-11-13       Impact factor: 1.440

Review 4.  Human cryptosporidiosis in Iran: a systematic review and meta-analysis.

Authors:  Reza Berahmat; Adel Spotin; Ehsan Ahmadpour; Mahmoud Mahami-Oskouei; Azim Rezamand; Nayyereh Aminisani; Morteza Ghojazadeh; Roghayeh Ghoyounchi; Tahereh Mikaeili-Galeh
Journal:  Parasitol Res       Date:  2017-01-21       Impact factor: 2.289

5.  Cryptosporidiosis - an occupational risk and a disregarded disease in Estonia.

Authors:  Brian Lassen; Marie Ståhl; Heidi L Enemark
Journal:  Acta Vet Scand       Date:  2014-06-05       Impact factor: 1.695

6.  Molecular appraisal of intestinal parasitic infection in transplant recipients.

Authors:  Pooja Yadav; Shehla Khalil; Bijay Ranjan Mirdha
Journal:  Indian J Med Res       Date:  2016-08       Impact factor: 2.375

Review 7.  Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis.

Authors:  Ze-Dong Wang; Quan Liu; Huan-Huan Liu; Shuang Li; Li Zhang; Yong-Kun Zhao; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2018-01-09       Impact factor: 3.876

8.  Colorectal cancer and Cryptosporidium spp. infection.

Authors:  Violetta Sulżyc-Bielicka; Lidia Kołodziejczyk; Sylwia Jaczewska; Dariusz Bielicki; Krzysztof Safranow; Paweł Bielicki; Józef Kładny; Wojciech Rogowski
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

9.  Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis.

Authors:  Fernando Valenzuela; Kim A Papp; David Pariser; Stephen K Tyring; Robert Wolk; Marjorie Buonanno; Jeff Wang; Huaming Tan; Hernan Valdez
Journal:  BMC Dermatol       Date:  2015-05-08

10.  Cryptosporidiosis in Iranian Farm Workers and Their Household Members: A Hypothesis about Possible Zoonotic Transmission.

Authors:  Morteza Izadi; Nematollah Jonaidi-Jafari; Amin Saburi; Hossein Eyni; Mohammad-Reza Rezaiemanesh; Reza Ranjbar
Journal:  J Trop Med       Date:  2014-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.